A carregar...
Osimertinib-Induced Cardiomyopathy
Osimertinib is the preferred treatment in patients with metastatic non–small cell lung cancer with epidermal growth factor receptor mutations. We report a case series of acute cardiomyopathy with heart failure exacerbation during osimertinib treatment. We suggest that cardiotoxicity from osimertinib...
Na minha lista:
| Publicado no: | JACC Case Rep |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8298525/ https://ncbi.nlm.nih.gov/pubmed/34317311 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaccas.2019.12.038 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|